Firstly I would like to acknowledge that no drug is free from side effects. Pioglitazone
is one of the three drugs in Triglycomet used for diabetes
treament It was banned in India due to its link with bladder cancer
and other side effects such as water retention, anemia and even heart failure
. But experts say that its benefits outweigh the risks and the ban was lifted in august.The lifting of the ban gave relief to over 35 lakh diabetes patients across the country who were left to either switch to insulin or opt for costlier (yet less effective) drugs.Now pioglitazone is available with a warning box on the packaging, warning of its risks for those with active bladder cancer, ongoing chemotherapy
and other such conditions.You may consult your doctor for change of prescription to other classes of drugs like insulin, gliptins or glp agonist etc.